Reaction
Allogenic Stem Cell Transplantation reporting signals
As of the last recalculation, Allogenic Stem Cell Transplantation appears in 154 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 549.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Azacitidine For | 50 | 549.7 | 551.2 |
| Venetoclax | 83 | 394.0 | 394.5 |
| Azacitidine | 51 | 346.9 | 347.5 |
| Posaconazole Delayed-Release | 16 | 219.6 | 219.9 |
| Busulfan | 18 | 174.9 | 175.1 |
| Posaconazole | 17 | 158.8 | 159.0 |
| Fludarabine Phosphate | 26 | 107.3 | 107.4 |
| Micafungin Sodium | 4 | 65.4 | 65.5 |
| Obinutuzumab | 7 | 60.2 | 60.2 |
| Blinatumomab | 4 | 53.2 | 53.2 |